Stress, Nerves, and Basophils: β₂-Adrenergic Signaling as a New Driver of Atopic Dermatitis ➜ DOI: 10.1016/j.immuni.2026.01.010 A new study in Immunity shows that sympathetic stress signaling can amplify atopic dermatitis–like inflammation in mice through β₂-adrenergic receptors on basophils. Norepinephrine released from sympathetic nerves promoted basophil migration and activation via an ADRβ₂–CCL6–CCR1 axis, while β₂ blockade or basophil-specific Adrb2 deletion reduced skin inflammation. Human AD samples showed increased sympathetic fibers and expression of ADRβ₂-related chemokine pathways, suggesting translational relevance. Although still preclinical, the work highlights a neuro-immune pathway linking stress and skin inflammation that may represent a future therapeutic target.
Of note, the senior author Fang WANG—a leader in neuro-immune research—was recently awarded the Rajka Medal, recognizing major contributions to atopic dermatitis research.
Plasma Lipids Feed the Skin Barrier: MFSD2A Links Systemic Lipid Transport to Epidermal Homeostasis ➜ DOI: 10.1073/pnas.2531159123 A new PNAS study identifies MFSD2A, a lysophosphatidylcholine (LPC) transporter, as a key pathway by which keratinocytes import plasma-derived lipid precursors required for epidermal differentiation. In mice, epidermal Mfsd2a deletion caused dermatitis, defective desquamation, and altered keratinocyte differentiation, associated with reduced phospholipids containing linoleic acid, a critical precursor for barrier lipids. Functional experiments in human keratinocytes confirmed that LPC-18:1 and LPC-18:2 promote differentiation in an MFSD2A-dependent manner. Interestingly, MFSD2A expression appears reduced in “eczema” keratinocytes, suggesting potential relevance to barrier disorders such as atopic dermatitis. This work introduces the concept that circulating phospholipids may directly supply substrates for epidermal barrier lipid synthesis, opening new perspectives on lipid metabolism and skin barrier repair.
Acral Dermatoses Beyond Morphology: Toward Immune-Guided Classification and Therapy ➜ DOI: 10.1016/j.jaci.2026.01.011 + 10.1111/all.70263 Two recent studies illustrate the complexity of inflammatory palmoplantar dermatoses. A JACI molecular profiling study identifies four immune endotypes (TH2, TH2/TH1 macrophage, TH17, and neutrophilic), revealing frequent clinical misclassification of acral eczema and psoriasis. In parallel, an Allergy phase 2b trial integrating transcriptomics with a randomized clinical trial shows that chronic hand eczema displays mixed type-1/2/3 immune signatures but responds significantly to IL-4Rα blockade with dupilumab, independent of classical atopic features. Together, these studies support the concept that immune pathway dominance may guide therapy more effectively than morphology alone. However, small exploratory cohorts, heterogeneous phenotypes, and the rarity of true palmoplantar AD highlight the need for larger prospective studies before molecular stratification becomes routine in clinical dermatology.
Beyond TARC: Monitoring Atopic Dermatitis in the Era of Biologics ➜ DOI: 10.1111/all.70248 Serum CCL17/TARC is widely used in Japan as a biomarker of AD severity, correlating well with clinical scores. In a longitudinal study of dupilumab-treated patients, however, TARC rapidly declined after treatment initiation and lost its correlation with disease activity. In contrast, IL-22—and to a lesser extent IL-18—remained consistently associated with EASI scores throughout therapy, suggesting they may better reflect residual inflammation under IL-4R blockade. These findings highlight how biomarkers may behave differently once targeted therapies suppress dominant pathways, and support the need for complementary markers capturing non–Th2 inflammation during treatment.
When Itch Speaks: Do Sensory Descriptors Reflect Different Cytokine Pathways? ➜ DOI: 10.1016/j.mayocpiqo.2026.100695 A study in Mayo Clinic Proceedings: Innovations, Quality & Outcomes explores whether qualitative aspects of itch in atopic dermatitis correspond to different biological pathways. In 132 Japanese adults with AD, a “crawling-like ants” sensation correlated with elevated IL-31, whereas stinging, stabbing, and burning sensations were associated with higher TARC/CCL17 levels and greater disease severity. These findings suggest that itch may cluster into IL-31–related and TARC-related patterns, linking sensory perception with neuroimmune mechanisms. While intriguing, the correlations remain exploratory and the cytokine panel incomplete. The study nonetheless reminds us that itch is not only quantitative but also qualitative, and that careful clinical interviewing may provide clues to the underlying biology of pruritus.
